» Articles » PMID: 31193162

Thiamine and Benfotiamine Protect Neuroblastoma Cells Against Paraquat and β-amyloid Toxicity by a Coenzyme-independent Mechanism

Overview
Journal Heliyon
Specialty Social Sciences
Date 2019 Jun 14
PMID 31193162
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Benfotiamine (BFT) is a synthetic thiamine precursor with high bioavailability. It is efficient in treating complications of type 2 diabetes and has beneficial effects in mouse models of neurodegenerative diseases. The mechanism of action of BFT remains unknown, though it is sometimes suggested that it may be linked to increased thiamine diphosphate (ThDP) coenzyme function.

Methods: We used a mouse neuroblastoma cell line (Neuro2a) grown in thiamine-restricted medium. The cells were stressed by exposure to paraquat (PQ) or amyloid β peptide in the presence or absence of BFT and the cell survival was measured using the MTT method. In each case, BFT was compared with sulbutiamine (SuBT), an unrelated thiamine precursor, and thiamine. Metabolites of BFT were determined by HPLC and mass spectrometry.

Results: At 50 μM, BFT protects the cells against PQ and amyloid β peptide-induced toxicity with the same efficacy. Protective effects were also observed with SuBT and with higher concentrations of thiamine. The main metabolites of BFT were thiamine and S-benzoylthiamine (S-BT). Treatment with both precursors induces a strong increase in intracellular content of thiamine. Protective effects of BFT and SuBT are directly related to thiamine (but not ThDP) levels in Neuro2a cells.

Conclusions: BFT, SuBT and thiamine all protect the cells against oxidative stress, suggesting an antioxidant effect of thiamine. Our results are not in favor of a direct ROS scavenging effect of thiamine but rather an indirect effect possibly mediated by some antioxidant signaling pathway. It is however not clear whether this effect is due to thiamine itself, its thiol form or an unknown metabolite.

General Significance: Our results suggest a role of thiamine in protection against oxidative stress, independent of the coenzyme function of thiamine diphosphate.

Citing Articles

Thiamine disulfide derivatives in thiol redox regulation: Role of thioredoxin and glutathione systems.

Folda A, Scalcon V, Tonolo F, Rigobello M, Bindoli A Biofactors. 2024; 51(1):e2121.

PMID: 39302148 PMC: 11681303. DOI: 10.1002/biof.2121.


Thiamine and benfotiamine: Focus on their therapeutic potential.

Bozic I, Lavrnja I Heliyon. 2023; 9(11):e21839.

PMID: 38034619 PMC: 10682628. DOI: 10.1016/j.heliyon.2023.e21839.


Emerging Alzheimer's disease therapeutics: promising insights from lipid metabolism and microglia-focused interventions.

Tobeh N, Bruce K Front Aging Neurosci. 2023; 15:1259012.

PMID: 38020773 PMC: 10630922. DOI: 10.3389/fnagi.2023.1259012.


Ameliorative effects of thiamin on learning behavior and memory dysfunction in a rat model of hypothyroidism: implication of oxidative stress and acetylcholinesterase.

Saberi R, Mirazi N, Amirahmadi S, Kioumarsi Darbandi Z, Vafaee F, Rajabian A Metab Brain Dis. 2023; 38(8):2603-2613.

PMID: 37906392 DOI: 10.1007/s11011-023-01317-0.


Synthetic Thioesters of Thiamine: Promising Tools for Slowing Progression of Neurodegenerative Diseases.

Bettendorff L Int J Mol Sci. 2023; 24(14).

PMID: 37511056 PMC: 10379298. DOI: 10.3390/ijms241411296.


References
1.
Bettendorff L, Wins P . Thiamin diphosphate in biological chemistry: new aspects of thiamin metabolism, especially triphosphate derivatives acting other than as cofactors. FEBS J. 2009; 276(11):2917-25. DOI: 10.1111/j.1742-4658.2009.07019.x. View

2.
Bettendorff L, Peeters M, Jouan C, Wins P, Schoffeniels E . Determination of thiamin and its phosphate esters in cultured neurons and astrocytes using an ion-pair reversed-phase high-performance liquid chromatographic method. Anal Biochem. 1991; 198(1):52-9. DOI: 10.1016/0003-2697(91)90505-n. View

3.
Stepuro A, Piletskaya T, Stepuro I . Role of thiamine thiol form in nitric oxide metabolism. Biochemistry (Mosc). 2005; 70(3):339-49. DOI: 10.1007/s10541-005-0120-5. View

4.
Tebay L, Robertson H, Durant S, Vitale S, Penning T, Dinkova-Kostova A . Mechanisms of activation of the transcription factor Nrf2 by redox stressors, nutrient cues, and energy status and the pathways through which it attenuates degenerative disease. Free Radic Biol Med. 2015; 88(Pt B):108-146. PMC: 4659505. DOI: 10.1016/j.freeradbiomed.2015.06.021. View

5.
Sevim S, Kaleagasi H, Tasdelen B . Sulbutiamine shows promising results in reducing fatigue in patients with multiple sclerosis. Mult Scler Relat Disord. 2017; 16:40-43. DOI: 10.1016/j.msard.2017.05.010. View